These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24406376)

  • 21. Exposure to iodomethane and dichloromethane associated with a confusional state.
    Ehler E; Latta J; Eichlerová A; Mrklovský M; Urban P
    Neurotoxicology; 2011 Jun; 32(3):307-11. PubMed ID: 21329723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of cognitive malingering in persons reporting exposure to occupational and environmental substances.
    Greve KW; Bianchini KJ; Black FW; Heinly MT; Love JM; Swift DA; Ciota M
    Neurotoxicology; 2006 Dec; 27(6):940-50. PubMed ID: 16904749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative EEG in occupational chronic solvent encephalopathy.
    Keski-Säntti P; Kovala T; Holm A; Hyvärinen HK; Sainio M
    Hum Exp Toxicol; 2008 Apr; 27(4):315-20. PubMed ID: 18684802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequelae of fume exposure in confined space welding: a neurological and neuropsychological case series.
    Bowler RM; Nakagawa S; Drezgic M; Roels HA; Park RM; Diamond E; Mergler D; Bouchard M; Bowler RP; Koller W
    Neurotoxicology; 2007 Mar; 28(2):298-311. PubMed ID: 17169432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Brain damage caused by exposure to organic solvents; diagnostics and disease course of chronic solvent-induced encephalopathy].
    van Valen E; van Hout ES; Wekking EM; Lenderink AF; van der Laan G; Hageman G
    Ned Tijdschr Geneeskd; 2015; 159():A9431. PubMed ID: 26732212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosing solvent-induced chronic toxic encephalopathy: the effect of underperformance in neuropsychological testing.
    Mestdagh I; van Bergen L; Kocken C; Heyvaert V; Cras P; Van Den Eede F
    Int J Psychiatry Clin Pract; 2019 Sep; 23(3):171-177. PubMed ID: 31082289
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of the French version of EUROQUEST: a questionnaire for neurotoxic symptoms.
    Rouch I; Wild P; Fontana JM; Chouaniere D
    Neurotoxicology; 2003 Aug; 24(4-5):541-6. PubMed ID: 12900067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Occupational neurointoxications: patterns and mechanisms of formation].
    Rukavishnikov VS; Lakhman OL; Sosedova LM; Shaiakhmetov SF; Bodienkova GM; Kudaeva IV; Katamanova EV; Konstantinova TN
    Med Tr Prom Ekol; 2014; (4):1-6. PubMed ID: 25051666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Solvent-induced chronic encephalopathy; the 'solvent team' project].
    van der Hoek JA; Verberk MM; van der Laan G; Hageman G
    Ned Tijdschr Geneeskd; 2001 Feb; 145(6):256-60. PubMed ID: 11236371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The applicability of WHO-NCTB in Korea.
    Kang SK
    Neurotoxicology; 2000 Oct; 21(5):697-701. PubMed ID: 11130273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reconsideration of the WHO NCTB strategy and test selection.
    Anger WK
    Neurotoxicology; 2014 Dec; 45():224-31. PubMed ID: 25172409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurobehavioral study on the interactive effects of age and solvent exposure.
    Kiesswetter E; Sietmann B; Zupanic M; Seeber A
    Neurotoxicology; 2000 Oct; 21(5):685-95. PubMed ID: 11130272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of reliability of traditional and computerized neurobehavioral tests.
    Sakong J; Kang PS; Kim CY; Hwang TY; Jeon MJ; Park SY; Lee SJ; Won KC; Lee SB; Chung JH
    Neurotoxicology; 2007 Mar; 28(2):235-9. PubMed ID: 16620994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptoms of chronic solvent encephalopathy: Euroquest questionnaire study.
    Kaukiainen A; Hyvärinen HK; Akila R; Sainio M
    Neurotoxicology; 2009 Nov; 30(6):1187-94. PubMed ID: 19963103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost of detecting a chronic solvent encephalopathy case by screening.
    Furu H; Sainio M; Ahonen G; Hyvärinen HK; Kaukiainen A
    Neurotoxicology; 2014 Dec; 45():253-9. PubMed ID: 24463353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solvent-related chronic toxic encephalopathy as a target in the worker's mental health research.
    Ramos A; Jardim SR; Silva-Filho JF
    An Acad Bras Cienc; 2004 Dec; 76(4):757-69. PubMed ID: 15558155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using self-report measures in neurobehavioural toxicology: can they be trusted?
    Williamson A
    Neurotoxicology; 2007 Mar; 28(2):227-34. PubMed ID: 16620990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inclusion of psychopathologic methods for diagnosis of early neurotoxic effects from lead and organic solvent mixtures].
    Pfister E; Böckelmann I; Darius S; Wurthmann C
    Fortschr Neurol Psychiatr; 1999 Oct; 67(10):435-40. PubMed ID: 10596364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychosocial and cognitive rehabilitation of patients with solvent-induced chronic toxic encephalopathy: a randomised controlled study.
    van Hout MS; Wekking EM; Berg IJ; Deelman BG
    Psychother Psychosom; 2008; 77(5):289-97. PubMed ID: 18560254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malingered neurocognitive dysfunction in neurotoxic exposure: an application of the Slick criteria.
    Morton WE
    J Occup Environ Med; 2004 Mar; 46(3):193; author reply 193-5. PubMed ID: 15091278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.